The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized double-blind, placebo-controlled phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel.
H. I. Scher
Consultant or Advisory Role - Cougar Biotechnology; Veridex
Honoraria - Cougar Biotechnology
G. Heller
Consultant or Advisory Role - Veridex (U)
A. Molina
Employment or Leadership Position - Cougar Biotechnology
Stock Ownership - Johnson & Johnson
T. S. Kheoh
Employment or Leadership Position - Cougar Biotechnology
Stock Ownership - Johnson & Johnson
G. Attard
Employment or Leadership Position - The Institute of Cancer Research
Other Remuneration - The Institute of Cancer Research
J. Moreira
No relevant relationships to disclose
S. K. Sandhu
No relevant relationships to disclose
C. Parker
Honoraria - Janssen-Ortho
C. Logothetis
Consultant or Advisory Role - Cougar Biotechnology
Honoraria - Cougar Biotechnology
Research Funding - Cougar Biotechnology
R. T. McCormack
Employment or Leadership Position - Veridex
Stock Ownership - Johnson & Johnson
K. Fizazi
Employment or Leadership Position - Cougar Biotechnology
Consultant or Advisory Role - Cougar Biotechnology; Janssen-Ortho
Honoraria - Cougar Biotechnology; Janssen-Ortho
A. Anand
No relevant relationships to disclose
D. C. Danila
Consultant or Advisory Role - Cougar Biotechnology (U)
M. Fleisher
No relevant relationships to disclose
D. Olmos
Honoraria - Veridex
C. M. Haqq
Employment or Leadership Position - Ortho Biotech
Stock Ownership - Johnson & Johnson
J. S. De Bono
Honoraria - Johnson & Johnson